235 related articles for article (PubMed ID: 9059472)
1. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
Burdet L; de Muralt B; Schutz Y; Fitting JW
Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
[TBL] [Abstract][Full Text] [Related]
2. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
3. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
4. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
[TBL] [Abstract][Full Text] [Related]
5. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of bronchodilating drugs in the treatment of stable COPD].
Nishimura K; Koyama H; Izumi T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
[TBL] [Abstract][Full Text] [Related]
7. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Colice GL
Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
[TBL] [Abstract][Full Text] [Related]
8. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
Koutsogiannis Z; Kelly AM
Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.
van Noord JA; de Munck DR; Bantje TA; Hop WC; Akveld ML; Bommer AM
Eur Respir J; 2000 May; 15(5):878-85. PubMed ID: 10853852
[TBL] [Abstract][Full Text] [Related]
10. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Pillet O; Manier G; Castaing Y
Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
[TBL] [Abstract][Full Text] [Related]
11. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
[TBL] [Abstract][Full Text] [Related]
12. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
Norris V; Ambery C
Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
[TBL] [Abstract][Full Text] [Related]
15. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
[TBL] [Abstract][Full Text] [Related]
16. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Matera MG; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
Pulm Pharmacol; 1995 Dec; 8(6):267-71. PubMed ID: 8819181
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction.
Barros MJ; Rees PJ
Respir Med; 1990 Sep; 84(5):371-5. PubMed ID: 2147295
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
[TBL] [Abstract][Full Text] [Related]
20. Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD.
De Backer LA; Vos WG; Salgado R; De Backer JW; Devolder A; Verhulst SL; Claes R; Germonpré PR; De Backer WA
Int J Chron Obstruct Pulmon Dis; 2011; 6():637-46. PubMed ID: 22162649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]